Before submitting your IIR budget, please ensure that all study-related expenses have been itemised and reflect fair market value. ResMed will consider funding activities related to both direct (subject-related costs, study-related personnel costs, diagnostic fees/services and external data management expenses, etc.) and indirect study costs (IRB review fees, equipment and supply expenses). ResMed will not compensate for the following: general education, training activities not specific to the study, support for ongoing clinical programs that are part of an organisation’s routine operations, start-up funds to establish new clinical or research programs or to expand existing programs, purchase of capital equipment unrelated to the study or that would generate revenue, construction funds or hiring of staff that are not dedicated to the study. Typically, we would expect that no government or commercial payor will be billed for patient therapy using devices that are provided by ResMed for use in the study.